Researching Modifiable and Non-Modifiable Risk Factors Linked to Cognitive Resilience in Alzheimer’s Disease
What do we do?
Our lab focuses on clarifying how alterations in the brain and other biomolecules (such as cerebrospinal fluid β-amyloid) place some cognitively-normal individuals on a pernicious trajectory that culminates in Alzheimer’s dementia. In this context, we are particularly interested in discovering new knowledge concerning the modulation of the link between brain changes and cognitive decline by both modifiable (e.g., cognitively-stimulating activities, physical exercise) and non-modifiable (e.g., genetic vulnerability) factors. Overlaid on this research agenda are investigations of health accessibility, and how such accessibility exacerbates or ameliorates the impact of biomarkers on clinical phenotypes.
We use many techniques in our research, including but not limited to:
This is an accordion element with a series of buttons that open and close related content panels.
MRI and PET Imaging


Cerebrospinal Fluid Collection

Maximal Exercise Testing


Blood-based Biomarkers

Physical Activity Monitoring

Cognitive Testing

We are a part of the larger Wisconsin Alzheimer’s Disease Research Program, which includes both the Wisconsin Alzheimer’s Disease Research Center and the Wisconsin Alzheimer’s Institute.
Our offices are located on UW Madison’s campus within the UW Hospital and WARF. The majority of our research is conducted at the UW Hospital, the Waisman Center, the Wisconsin Institute for Medical Research, and the YMCA.
News Highlights

Leah Symanski Accepted Into Medical School
Leah Symanski was accepted into the Central Michigan University College of Medicine and will start in August 2026. Congratulations on this achievement, Leah! We are so proud of you and know you will be an …
July 6, 2026
Gabriella Mamlouk Invited to Co-Chair Developing Topics Session at AAIC 2026
Gabriella Mamlouk has been invited to co-chair a Developing Topics session at AAIC this year! She will be moderating alongside another session chair, which is a fantastic recognition of her expertise and contributions to AAIC the …
July 6, 2026
Asha Coy Accepted Into Medical School
Asha Coy was accepted into the Marian University College of Osteopathic Medicine in Indianapolis. She will start this August, and we couldn’t be more excited for her. Congratulations, Asha – we are beyond proud of …
June 12, 2026
Sara Fernandes-Taylor’s Manuscript Accepted for Publication
Sara Fernandes-Taylor’s manuscript “Neurodegeneration, neuroinflammation, and synaptic dysfunction biomarkers in cognitively unimpaired people with advanced Alzheimer pathology” has been accepted for publication in Neurology Open Access. Congratulations, SFT!
June 8, 2026- More News





